- Home
- BLRX vs LEDS Comparison
BLRX vs LEDS Comparison
Compare BLRX & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- LEDS
- Stock Information
- Founded
- BLRX 2003
- LEDS 2005
- Country
- BLRX Israel
- LEDS Taiwan
- Employees
- BLRX N/A
- LEDS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- BLRX Health Care
- LEDS Technology
- Exchange
- BLRX Nasdaq
- LEDS Nasdaq
- Market Cap
- BLRX 12.1M
- LEDS 20.3M
- IPO Year
- BLRX 2011
- LEDS 2010
- Fundamental
- Price
- BLRX $5.25
- LEDS $2.98
- Analyst Decision
- BLRX Strong Buy
- LEDS
- Analyst Count
- BLRX 2
- LEDS 0
- Target Price
- BLRX $19.00
- LEDS N/A
- AVG Volume (30 Days)
- BLRX 1.9M
- LEDS 76.0K
- Earning Date
- BLRX 05-27-2025
- LEDS 07-07-2025
- Dividend Yield
- BLRX N/A
- LEDS N/A
- EPS Growth
- BLRX N/A
- LEDS N/A
- EPS
- BLRX N/A
- LEDS N/A
- Revenue
- BLRX $22,340,000.00
- LEDS $14,780,000.00
- Revenue This Year
- BLRX N/A
- LEDS N/A
- Revenue Next Year
- BLRX N/A
- LEDS N/A
- P/E Ratio
- BLRX N/A
- LEDS N/A
- Revenue Growth
- BLRX 91.68
- LEDS 160.76
- 52 Week Low
- BLRX $2.30
- LEDS $0.92
- 52 Week High
- BLRX $35.60
- LEDS $3.07
- Technical
- Relative Strength Index (RSI)
- BLRX 84.90
- LEDS 68.64
- Support Level
- BLRX $3.32
- LEDS $2.32
- Resistance Level
- BLRX $3.97
- LEDS $2.80
- Average True Range (ATR)
- BLRX 0.46
- LEDS 0.25
- MACD
- BLRX 0.14
- LEDS 0.04
- Stochastic Oscillator
- BLRX 47.06
- LEDS 90.28
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.